News Minimalist logo

Oral spray vaccine MV140 prevents recurrent UTIs long-term

Cosmos — April 7, 2024, 03:00 AM UTC

Summary: A new oral spray-based vaccine, MV140, has shown to prevent recurrent UTIs for up to 9 years in 54% of recipients. Initial results presented at the EAU Congress reveal an average infection-free period of 54.7 months. The vaccine contains inactivated bacteria of major UTI-causing species and is administered daily for 3 months. Experts believe it could reduce antibiotic use and be a game changer in UTI prevention.

Full article

Article metrics
Significance6.2
Scale7.5
Magnitude7.0
Potential8.5
Novelty8.0
Actionability6.0
Immediacy7.0
Positivity9.0
Credibility9.0

Timeline:

  1. [5.3]
    Oral spray vaccine prevents UTIs for up to 9 years (ABC News)
    37d
    Source
  2. [4.6]
    MV140 oral spray vaccine for UTI shows long-term efficacy (Onmanorama)
    40d
    Source
  3. [5.3]
    Oral spray vaccine MV140 prevents recurrent UTIs for years (Connected to India)
    40d
    Source
  4. [5.1]
    Oral spray vaccine prevents UTIs for up to 9 years (The Independent)
    40d
    Source
  5. [4.2]
    Uromune vaccine shows promise in preventing recurring UTIs long-term (The Mirror)
    41d
    Source
  6. [6.6]
    Oral spray vaccine prevents recurring UTIs for up to 9 years (The Telegraph)
    41d

    ScoresSource